Amphastar Pharma (AMPH) Tops Q2 EPS by 11c

Amphastar Pharma (NASDAQ: AMPH) reported Q2 EPS of $0.85, $0.11 better than the analyst estimate of $0.74. Revenue for the quarter came in at $174.4 million versus the consensus estimate of $173.95 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• Goldman: 'Our key conclusion is that AI is likely to be credit-positive for banks', 'Rearming Our Overweight Stance on Banks'
• Trump: will probably let CNN, MSNOW and Politico back in to White House if judge decides
• Meta Platforms (META) spreader of March 900 and 1100 calls as share price up in last three weeks